EDGAR Filing Documents for 0001193125-18-247356

Form 8-K - Current report:

SEC Accession No. 0001193125-18-247356

Filing Date

2018-08-13

Accepted

2018-08-13 16:48:58

Documents

Period of Report

2018-08-10

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d607433d8k.htm	8-K	16526
2	EX-99.1	d607433dex991.htm	EX-99.1	44632
3	GRAPHIC	g607433g63x95.jpg	GRAPHIC	5153
	Complete submission text file	0001193125-18-247356.txt		69622

Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306

Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845

Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 181012856
SIC: 2836 Biological Products, (No Diagnostic Substances)